EGFR and non-small cell lung carcinoma: T790M abundance detected in plasma samples using ddPCR has clinical values in predicting the response to third-generation EGFR-TKIs in NSCLC patients; specifically, patients with a higher T790M abundance exceeding 0.43% may have a better response to the third-generation EGFR-TKIs.